These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 6967357)

  • 1. Locomotion of T cells from patients with cutaneous T-cell lymphoma (Sézary syndrome and mycosis fungoides).
    Gupta S; Safai B; Edelson R; Parrott D; Good R
    Cell Immunol; 1980 Mar; 50(1):195-201. PubMed ID: 6967357
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
    Edelson RL
    J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sézary syndrome. Clinical, immunological and proliferative kinetics].
    Marosi L; Hofer F; Schwarzmeier J; Konrad K; Knapp W; Radaskiewicz T
    Acta Med Austriaca; 1979; 6(5):237-40. PubMed ID: 318012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values.
    Wood GS; Hong SR; Sasaki DT; Abel EA; Hoppe RT; Warnke RA; Morhenn VB
    J Am Acad Dermatol; 1990 Apr; 22(4):602-7. PubMed ID: 1690762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome.
    Shono Y; Suga H; Kamijo H; Fujii H; Oka T; Miyagaki T; Shishido-Takahashi N; Sugaya M; Sato S
    Acta Derm Venereol; 2019 Jul; 99(9):809-812. PubMed ID: 31045236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for epigenetic factors in the pathogenesis of epidermotropic cutaneous T-cell lymphomas (mycosis fungoides and Sézary syndrome)?
    Bachelez H
    Hematol J; 2001; 2(4):286-9. PubMed ID: 11920262
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--part II.
    Safai B
    Clin Bull; 1977; 7(4):140-5. PubMed ID: 147147
    [No Abstract]   [Full Text] [Related]  

  • 8. IgG anti-50 kd lymphocyte membrane peptide antibody in patients with Sézary syndrome.
    D'Ambra-Cabry K; Tharp MD; Jagasothy BV; Deng JS
    J Am Acad Dermatol; 1996 May; 34(5 Pt 1):777-80. PubMed ID: 8632073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological characterization of malignant epidermotropic lymphoma cells in cutaneous infiltrates (author's transl)].
    Thivolet J; Souteyrand P; Alario A; Schmitt D; Perrot H
    Dermatologica; 1978; 157(6):357-64. PubMed ID: 363474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P; Burg G; Smolle J; Braun-Falco O
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subpopulations of human T lymphocytes. IV. Quantitation and distribution in patients with mycosis fungoides and Sézary syndrome.
    Gupta S; Safai B; Good RA
    Cell Immunol; 1978 Aug; 39(1):18-26. PubMed ID: 308846
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunobiology and treatment of cutaneous T-cell lymphoma.
    Goel RR; Rook AH
    Expert Rev Clin Immunol; 2024 Aug; 20(8):985-996. PubMed ID: 38450476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent cellular cytotoxicity in patients with mycosis fungoides and Sézary syndrome.
    Asbell SO; Gadol N; Saluk P; Vonderheid EC; Brady LW
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):609-13. PubMed ID: 101489
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous T-cell lymphomas. A review of the recent literature.
    Zackheim HS
    Arch Dermatol; 1981 May; 117(5):295-304. PubMed ID: 6971626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More about the T-cell receptor V beta repertoire usage in mycosis fungoides/Sézary syndrome.
    Bachelez H; Gorochov G
    Br J Dermatol; 1995 Jun; 132(6):1017-8. PubMed ID: 7662555
    [No Abstract]   [Full Text] [Related]  

  • 16. OKT 9 reactivity in mycosis fungoides and large plaque (atrophic) parapsoriasis.
    McMillan EM; Wasik R; Peters S; Jackson I; Stoneking L; Everett MA
    Cancer; 1983 Apr; 51(8):1403-7. PubMed ID: 6337701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.
    Meyerson HJ; Awadallah A; Pavlidakey P; Cooper K; Honda K; Miedler J
    Mod Pathol; 2013 Jan; 26(1):32-43. PubMed ID: 22918164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.
    Ralfkiaer E; Saati TA; Bosq J; Delsol G; Gatter KC; Mason DY
    J Clin Pathol; 1986 May; 39(5):553-63. PubMed ID: 3522633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patch tests in Sézary syndrome and mycosis fungoides.
    Shupp DL; Winkelmann RK
    Contact Dermatitis; 1985 Sep; 13(3):180-5. PubMed ID: 4053598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.